Product Overview
AMOXIMED LA is a long-acting veterinary injectable suspension containing amoxicillin at a concentration of 150 mg/ml. A single administration of this formulation provides sustained antimicrobial action. It is intended for cattle and dogs for the treatment of infections caused by amoxicillin-susceptible bacteria.
Indications
AMOXIMED LA is used in cattle and dogs for the treatment of infections caused by bacteria susceptible to amoxicillin.
The product is indicated for the treatment of infections of:
- Digestive tract
- Respiratory tract
- Urogenital tract
- Skin and soft tissues
It is also indicated for the prevention of post-operative infections through preoperative treatment, where caused by amoxicillin-susceptible bacteria.
Dosage and Administration
Recommended dose: 15 mg amoxicillin per kg body weight, equivalent to 1 ml of AMOXIMED LA per 10 kg body weight.
Cattle
10 ml per 100 kg body weight.
Route: Intramuscular injection.
Dogs
2 ml per 20 kg body weight.
Route: Intramuscular or subcutaneous injection.
Use During Pregnancy and Lactation
No specific restrictions are stated in the supplied product information.
Use only in accordance with the benefit/risk assessment of the responsible veterinarian.
Withdrawal Period
Cattle
- Meat and offal: 23 days.
- Milk: 3 days.
Withdrawal periods for dogs were not specified in the supplied product information.
Storage and Shelf Life
Packaging
Glass vial: 1 × 100 ml, packed in a cardboard box.
Product Classification
Manufacturer
AVE & VETMEDIC DOO
Production Site:
Bregalnicka 32, 26300 Vršac, Republic of Serbia
Head Office:
Petra Lekovica 6, 11000 Belgrade, Republic of Serbia
Exclusive Agency and Distribution in Iran
FAAM ZARIN KIMIA AVAR COMPANY
Responsible for exclusive agency rights, marketing, distribution and importing in Iran.
Unit 2 (West), No. 458, Jamalzadeh Shomali, Tehran, Iran.